S
Spica Therapeutics develops transformative therapies by leveraging proprietary functional macrophage fingerprinting technology to identify and selectively target disease-relevant macrophage subsets. The company focuses on addressing unmet medical needs in oncology, fibroinflammatory, and autoimmune diseases through precise immune modulation. This approach aims to create novel therapeutic candidates with improved patient outcomes across multiple indications.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Spica Therapeutics develops novel therapies by leveraging proprietary functional macrophage fingerprinting technology to identify and selectively target disease-relevant macrophage subsets. The company focuses on creating breakthrough treatments for unmet medical needs in oncology, fibroinflammatory, and autoimmune diseases. This platform aims to modulate macrophage activity to improve patient outcomes across multiple therapeutic areas.